Disulfide-stabilized diabody antiCD19/antiCD3 exceeds its parental antibody in tumor-targeting activity. (Q54325947)

27 May 2018

title

Disulfide-stabilized diabody antiCD19/antiCD3 exceeds its parental antibody in tumor-targeting activity. (English)

1 reference

27 May 2018

author name string

Li Wei

1

1 reference

27 May 2018

Fan Dongmei

2

1 reference

27 May 2018

Yang Ming

3

1 reference

27 May 2018

Shi Ruizan

4

1 reference

27 May 2018

Yan Yan

5

1 reference

27 May 2018

Jiang Linlin

6

1 reference

27 May 2018

Yan Cihui

7

1 reference

27 May 2018

Li Shuangjing

8

1 reference

27 May 2018

Wang Min

9

1 reference

27 May 2018

Wang Jianxiang

10

1 reference

27 May 2018

Xiong Dongsheng

11

1 reference

27 May 2018

publication date

9 October 2012

1 reference

27 May 2018

published in

Cellular Oncology

1 reference

27 May 2018

volume

35

1 reference

27 May 2018

issue

6

1 reference

27 May 2018

page(s)

423-434

1 reference

27 May 2018

Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria--a population-based report of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0101-9

Monoclonal antibodies in the treatment of lymphoid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0101-9

Evolution of anti-CD20 monoclonal antibody therapeutics in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0101-9

Optimization of antibody binding to FcgammaRIIa enhances macrophage phagocytosis of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0101-9

Bispecific antibodies targeting cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0101-9

Strictly target cell-dependent activation of T cells by bispecific single-chain antibody constructs of the BiTE class

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0101-9

Improvement of tumor targeting and antitumor activity by a disulphide bond stabilized diabody expressed in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0101-9

T-cell activation and B-cell depletion in chimpanzees treated with a bispecific anti-CD19/anti-CD3 single-chain antibody construct

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0101-9

Bispecific antibodies engage T cells for antitumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0101-9

"Diabodies": small bivalent and bispecific antibody fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0101-9

High level secretion of a humanized bispecific diabody from Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0101-9

Toward the production of bispecific antibody fragments for clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0101-9

Engineering interchain disulfide bonds into conserved framework regions of Fv fragments: improved biochemical characteristics of recombinant immunotoxins containing disulfide-stabilized Fv.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0101-9

Cytosine arabinoside induces costimulatory molecule expression in acute myeloid leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0101-9

Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0101-9

Multidrug resistance phenotype in high grade soft tissue sarcoma: correlation of P-glycoprotein immunohistochemistry with pathologic response to chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0101-9

Multidrug resistance P-glycoprotein monoclonal antibody JSB-1 crossreacts with pyruvate carboxylase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13402-012-0101-9

[The influence of Ara-C on anti-CD3/anti-Pgp mediating T-lymphocytes activities against multi-drug resistant leukemia cells.].

21 January 2018

1 reference

12 December 2020

Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library.

1 reference

12 December 2020

Use of rituximab, the new FDA-approved antibody.

1 reference

12 December 2020

A recombinant bispecific single-chain antibody, CD19 x CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes.

1 reference

12 December 2020

[A high affinity CD3 monoclonal antibody HIT3a. I. Production and identification]

1 reference

12 December 2020

[Construction and expression of single chain variable fragments (ScFv) against human CD19 antigen]

1 reference

12 December 2020

Bispecific antibodies for polyclonal T-cell engagement

1 reference

12 December 2020

Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma

1 reference

12 December 2020

Antitumor activity and pharmacokinetics in mice of a recombinant immunotoxin containing a disulfide-stabilized Fv fragment

1 reference

12 December 2020

[The mutation of anti-CD3 antibody (HIT3a) gene and its expression]

1 reference

12 December 2020

Improved binding and antitumor activity of a recombinant anti-erbB2 immunotoxin by disulfide stabilization of the Fv fragment

1 reference

12 December 2020

Cytotoxic and antitumor activity of a recombinant immunotoxin composed of disulfide-stabilized anti-Tac Fv fragment and truncated Pseudomonas exotoxin

1 reference

12 December 2020

Antibody engineering of recombinant Fv immunotoxins for improved targeting of cancer: disulfide-stabilized Fv immunotoxins.

1 reference

12 December 2020

Influence of FcγRIIIa polymorphism on rituximab-dependent NK cell-mediated cytotoxicity to Raji cells

1 reference

12 December 2020

Chemical production of bispecific antibodies

1 reference

12 December 2020

10.1007/S13402-012-0101-9

Identifiers

DOI

1 reference

27 May 2018

1 reference

27 May 2018